CAPPED BONUSZERTIFIKAT - MERCK & CO. Stock

Certificat

DE000PC67NA1

Market Closed - Börse Stuttgart 03:46:20 2024-06-07 am EDT
101.5 EUR +0.11% Intraday chart for CAPPED BONUSZERTIFIKAT - MERCK & CO.
Current month+1.43%
1 month-0.06%
Date Price Change
24-06-07 101.5 +0.11%
24-06-06 101.4 +0.26%
24-06-05 101.1 +0.40%
24-06-04 100.7 +0.48%
24-06-03 100.2 +0.18%

Delayed Quote Börse Stuttgart

Last update June 07, 2024 at 03:46 am EDT

More quotes

Static data

Product typeBonus- and Part-Guarantee-Certificates
Buy / SellCALL
Underlying MERCK & CO., INC.
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC67NA
ISINDE000PC67NA1
Date issued 2024-03-25
Strike 120 $
Maturity 2025-06-20 (378 Days)
Parity 1 : 1
Emission price 97.12
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 102.3
Lowest since issue 98.84
Spread 0.02
Spread %0.02%

Company Profile

Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows: - sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.; - sale of vaccines (18%); - sale of animal health products (9.4%); - other (2.9%). Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
More about the company

Ratings for Merck & Co., Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Merck & Co., Inc.

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
130.7 USD
Average target price
142.7 USD
Spread / Average Target
+9.19%
Consensus